Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al B Benson

Showing results (211-220 of 350) with videos related to

Pageof 35
Sort By:
JNCI Cancer Spectrum|May 27, 2020
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon CancerFrank A Sinicrope, Qian Shi, Fabienne Hermitte, et al.
American Journal of Clinical Pathology|January 13, 2017
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Christina B Ventura, et al.
Gastrointestinal Cancer Research : GCR|January 8, 2013
Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296)A Bapsi Chakravarthy, Paul J Catalano, Joshua K Mondschein, et al.
Archives of Pathology & Laboratory Medicine|November 15, 2016
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Christina B Ventura, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2013
Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II studyAl B Benson, Jean-Francois Geschwind, Mary F Mulcahy, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 20, 2023
Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal CancerPatrick McGarrah, Joleen Hubbard, Paul J Novotny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Carol Colasacco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 StudyJeffrey A Meyerhardt, Joel E Tepper, Donna Niedzwiecki, et al.
Journal of the National Cancer Institute|May 22, 2024
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208)Howard S Hochster, Paul Catalano, Michelle Weitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 7, 2013
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolizationRiad Salem, Margaret Gilbertsen, Zeeshan Butt, et al.
Pageof 35

Showing results (211-220 of 350) with videos related to

Sort By:
Pageof 35
JNCI Cancer Spectrum|May 27, 2020
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon CancerFrank A Sinicrope, Qian Shi, Fabienne Hermitte, et al.
American Journal of Clinical Pathology|January 13, 2017
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Christina B Ventura, et al.
Gastrointestinal Cancer Research : GCR|January 8, 2013
Phase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296)A Bapsi Chakravarthy, Paul J Catalano, Joshua K Mondschein, et al.
Archives of Pathology & Laboratory Medicine|November 15, 2016
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Christina B Ventura, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2013
Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II studyAl B Benson, Jean-Francois Geschwind, Mary F Mulcahy, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 20, 2023
Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal CancerPatrick McGarrah, Joleen Hubbard, Paul J Novotny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2017
HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical OncologyAngela N Bartley, Mary Kay Washington, Carol Colasacco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 StudyJeffrey A Meyerhardt, Joel E Tepper, Donna Niedzwiecki, et al.
Journal of the National Cancer Institute|May 22, 2024
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208)Howard S Hochster, Paul Catalano, Michelle Weitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 7, 2013
Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolizationRiad Salem, Margaret Gilbertsen, Zeeshan Butt, et al.
Pageof 35